The whole world of gambling is on your smartphone with the Mostbet app - join us!
Home  »  Trending   »  Analyzing the Price-to-Earnings Ratio of Axcella H...

Analyzing the Price-to-Earnings Ratio of Axcella Health Inc. (AXLA)

The 36-month beta value for AXLA is also noteworthy at 1.02. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”

The average price estimated by analysts for AXLA is $1.50, which is $4.93 above than the current price. The public float for AXLA is 55.86M, and at present, short sellers hold a 17.75% of that float. The average trading volume of AXLA on September 15, 2023 was 19.65M shares.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


AXLA) stock’s latest price update

The stock price of Axcella Health Inc. (NASDAQ: AXLA) has dropped by -30.00 compared to previous close of 1.01. Despite this, the company has seen a fall of -27.86% in its stock price over the last five trading days. InvestorPlace reported 2023-09-15 that Axcella Health (NASDAQ: AXLA ) stock is taking a beating on Friday after the biotechnology company announced plans for a reverse stock split. According to Axcella Health, shares of AXLA stock are going to undergo a one-for-25 reverse split.

AXLA’s Market Performance

AXLA’s stock has fallen by -27.86% in the past week, with a monthly rise of 343.82% and a quarterly rise of 125.88%. The volatility ratio for the week is 73.00% while the volatility levels for the last 30 days are 47.73% for Axcella Health Inc. The simple moving average for the last 20 days is 56.66% for AXLA’s stock, with a simple moving average of 63.31% for the last 200 days.

Analysts’ Opinion of AXLA

Many brokerage firms have already submitted their reports for AXLA stocks, with Noble Capital Markets repeating the rating for AXLA by listing it as a “Outperform.” The predicted price for AXLA in the upcoming period, according to Noble Capital Markets is $6 based on the research report published on October 12, 2021 of the previous year 2021.

AXLA Trading at 141.05% from the 50-Day Moving Average

After a stumble in the market that brought AXLA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -71.61% of loss for the given period.

Volatility was left at 47.73%, however, over the last 30 days, the volatility rate increased by 73.00%, as shares surge +321.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +218.18% upper at present.

During the last 5 trading sessions, AXLA fell by -28.57%, which changed the moving average for the period of 200-days by -19.52% in comparison to the 20-day moving average, which settled at $0.4780. In addition, Axcella Health Inc. saw 115.88% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at AXLA starting from Koziel Margaret, who sale 679 shares at the price of $0.58 back on Mar 01. After this action, Koziel Margaret now owns 24,883 shares of Axcella Health Inc., valued at $394 using the latest closing price.

Hinshaw William, the President & CEO of Axcella Health Inc., sale 16,000 shares at $1.56 during a trade that took place back on Oct 19, which means that Hinshaw William is holding 82,012 shares at $25,027 based on the most recent closing price.

Stock Fundamentals for AXLA

The total capital return value is set at -272.64, while invested capital returns managed to touch -313.39.

Based on Axcella Health Inc. (AXLA), the company’s capital structure generated 51.90 points at debt to equity in total, while total debt to capital is 34.17. Total debt to assets is 11.42, with long-term debt to equity ratio resting at 13.66. Finally, the long-term debt to capital ratio is 9.00.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.27.


In summary, Axcella Health Inc. (AXLA) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Should You Invest in BP p.l.c. (BP) Now?

BP p.l.c. (NYSE: BP) has a higher price-to-earnings ratio of 5.78x compared to its average ratio, and the 36-month beta value for BP is at